Molecular Epidemiologist Joins Cepheid to Head Healthcare-Associated Infection Consortium Program

Article

SUNNYVALE, Calif. -- Cepheid announces the appointment of leading molecular epidemiologist and expert on healthcare-associated infections, Fred Tenover, PhD, as senior director of scientific affairs. Tenover will serve as a liaison with the infection control community and will lead Cepheid's Healthcare Associated Infection (HAI) Consortium program.

"The objective of the Cepheid HAI Consortium is to establish global connections between hospital laboratories and leading academic laboratories in order to track evolving drug resistance patterns, virulence determinants, and the emergence of new strains associated with specific HAIs,” said David H. Persing, MD, PhD, chief medical and technology officer at Cepheid. “The resulting information will be used in the design of rapid and definitive new tests for HAIs and for ensuring that Cepheid's leadership

position in this area is maintained and expanded. Tenover is a noted microbiologist and authority on HAI-associated organisms and as such, is uniquely qualified to head Cepheid's HAI Consortium Program. I am extremely pleased to welcome such an accomplished scientist to our team and look forward to Fred's contribution as we continue to expand and refine our menu of molecular tests in this important developing market."

Tenover currently holds the position of distinguished consultant and director of the Office of Antimicrobial Resistance at the Centers for Disease Control and Prevention (CDC). In addition, Tenover is director of the Centers for Disease Control and Prevention/World Health Organization Collaborating Center for Global Antimicrobial Resistance Monitoring, and also is adjunct professor in the Department of Epidemiology at Emory University School of Public Health.

"Finding effective treatment for the increasing number of multiple antibiotic-resistant HAIs has become a serious challenge for physicians not only in U.S. hospitals but around the world," said Tenover. "Providing physicians with the critical laboratory data they need to make decisions within a few hours instead of a few days will not only save lives but will help control the spread of infections in healthcare settings. I am delighted to have the opportunity to join forces with the distinguished team of scientists at Cepheid to confront the increasing burden of HAIs on human health."

Tenover is expected to join the Cepheid team in early October.

Source: Cepheid

 

   

    

 

 

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content